Document 3Nro1rNM0D6NmdQzZqEd978zn

r Afua.6- <*+69 o 0 IW V. -TT E . I. du P o nt de N em o u r s & C o m pa n y Wilm in g to n . Delaw are 19898 EM PLOYEE RELATIONS DEPARTM EN T cc: B. H. Karrh/ J. C. Bonnett R. N. Ligo/ S. Pell < -- W. E. Fayerweather/File June 9, 1980 L. F. PERCIVAL POLYMER PRODUCTS DEPARTMENT WT 642 YOUR MEMO, JUNE 4, REQUESTING COMMENTS ON THE WASHINGTON WORKS COMMUNICATION DRAFT "FLUROSURFACTANTS IN BLOOD" I am concerned that the "Draft" implies that the Medical Division will not continue the study of liver tests on those employees potentially exposed to C-8. Even though we have found no "conclusive evidence of an occupationally related health problem," we still cannot explain why the mean SGOT was* significantly higher among TFE process workers and that the mean AP was significantly higher among FEP process and service workers. Therefore, I recommend the following changes to the Draft: At the end of the second paragraph, page 1, add: "However, it was recommended that the study of liver tests continue." e At the bottom of page 2, add a fourth item: "Continue to evaluate the liver tests of employees with potential exposure to C-8." Because of Bill Fayerweather's involvement, I would appre ciate your copying him in on any communication relating to the evaluation of workers exposed to C - 8 . He will be sending you and Dick the second draft of his epidemiological study within the next few days. MEDICAL DIVISION /' S lo ts ' VANN A. BREWSTER, M. D. ASSISTANT MEDICAL DIRECTOR VAB:mjk EID102477 WEF000044 o r T T f R t h i n g s r o n n f u r n i ivim . . t h u o i i g m r r < i^ r ' 000192